Essity AB: A Resilient Consumer Compounder with Margin Recovery and Innovation Catalysts

Essity AB (ESSITY-B.ST) is a leading global hygiene and health company with a portfolio of strong brands including TENA, Tork, and Libero. The company is undergoing a significant transformation focused on operational efficiency, premiumization, and sustainability, which we believe will drive margin expansion and earnings growth over the next 12 months.

Investment Thesis

Essity is a classic consumer compounder with defensive characteristics and secular growth drivers. The company benefits from aging demographics (incontinence products), increased hygiene awareness, and premium product innovation. After a period of cost inflation and supply chain disruption, Essity is now seeing input cost normalization and is executing a cost savings program targeting SEK 2 billion annually. We expect margins to recover to pre-pandemic levels, driving EPS growth of 10-15% annually.

12-Month Catalysts

  • Margin Recovery: Pulp prices have declined from 2022 peaks, and Essity’s cost savings program is on track. We expect EBIT margin to expand by 100-150 bps in 2025.
  • Premium Product Growth: TENA incontinence products and Tork professional hygiene are gaining market share. New product launches in sustainable packaging and reusable wipes are gaining traction.
  • Emerging Market Expansion: Essity has strong positions in Latin America and Asia, where hygiene product penetration is low. We expect mid-single-digit organic growth from these regions.

Key Risks

  • Raw Material Volatility: Pulp and energy costs remain volatile. A spike in input costs could pressure margins.
  • Currency Headwinds: Essity reports in SEK but has significant exposure to USD and EUR. A strong SEK could reduce reported earnings.

Valuation

Essity trades at 16x forward P/E, a discount to its historical average of 18x and to peers like Kimberly-Clark (20x). We see fair value at 20x, implying 25% upside.

Balance Sheet

Essity has a strong balance sheet with net debt/EBITDA of 1.5x and ample liquidity. The company generates strong free cash flow, supporting a dividend yield of 3.5% and share buybacks.

Disclaimer: This is not investment advice. Past performance is not indicative of future results. Investing involves risk, including loss of principal.